(Q33357606)

26 July 2017

title

New TPO treatment schedules of increased safety and efficacy: pre-clinical validation of a thrombopoiesis simulation model (English)

1 reference

26 July 2017

New TPO treatment schedules of increased safety and efficacy: pre‐clinical validation of a thrombopoiesis simulation model (English)

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04696.X

1 April 2024

7

Huub H D M van Vliet

0 references

author name string

Kirill Skomorovski

1

1 reference

26 July 2017

Hila Harpak

2

1 reference

26 July 2017

Anton Ianovski

3

1 reference

26 July 2017

Moshe Vardi

4

1 reference

26 July 2017

Gerard Wagemaker

8

1 reference

26 July 2017

Zvia Agur

9

1 reference

26 July 2017

Trudi P. Visser

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616973

1 April 2024

Simone C. C. Hartong

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616973

1 April 2024

Huub H. D M. van Vliet

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616973

1 April 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

26 July 2017

https://pure.eur.nl/files/46516843/Skomorovski_et_al-2013-British_Journal_of_Haematology.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616973

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2141.2003.04696.x

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04696.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2141.2003.04696.x

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04696.X

British Journal of Haematology

1 April 2024

published in

1 reference

26 July 2017

volume

123

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

683-691

1 reference

Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04696.X

Zidovudine toxicity to murine bone marrow may be affected by the exact frequency of drug administration

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04696.X

The impact of thrombopoietin on clinical practice

1 April 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04696.X

Pharmacokinetics and hematological effects of the PEGylated thrombopoietin peptide mimetic GW395058 in rats and monkeys after intravenous or subcutaneous administration

1 April 2024

7

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04696.X

Targeted approaches for the treatment of thrombocytopenia

1 April 2024

8

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04696.X

Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia

1 April 2024

10

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04696.X

Physiology and clinical applications of platelet growth factors

1 April 2024

12

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04696.X

Thrombopoietin as a drug: biologic expectations, clinical realities, and future directions

1 April 2024

15

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04696.X

In vivo effects of pegylated recombinant human megakaryocyte growth and development factor on hematopoiesis in normal mice

1 April 2024

16

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04696.X

Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo

1 April 2024

18

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04696.X

Relative number and proliferation kinetics of hemopoietic stem cells in the mouse

1 April 2024

25

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04696.X

Pharmacokinetics, pharmacodynamics, and safety of administering pegylated recombinant megakaryocyte growth and development factor to newborn rhesus monkeys

1 April 2024

27

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04696.X

The prolonged hematologic effects of a single injection of PEG-rHuMGDF in normal and thrombocytopenic mice

1 April 2024

29

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04696.X

In vivo expansion of hemopoietic stem cells

1 April 2024

32

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04696.X

1 April 2024

Identifiers

1 reference

release_xz5prga4srhddoyfsvqq67v7ju

26 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xz5prga4srhddoyfsvqq67v7ju

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference